Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Gross Margin: 2014-2025

Historic Gross Margin for Ascendis Pharma A (ASND) over the last 12 years, with Sep 2025 value amounting to 89.54%.

  • Ascendis Pharma A's Gross Margin rose 890.00% to 89.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 86.80%, marking a year-over-year increase of 197.00%. This contributed to the annual value of 87.83% for FY2024, which is 447.00% up from last year.
  • Latest data reveals that Ascendis Pharma A reported Gross Margin of 89.54% as of Q3 2025, which was up 11.78% from 80.10% recorded in Q2 2025.
  • In the past 5 years, Ascendis Pharma A's Gross Margin registered a high of 100.00% during Q1 2021, and its lowest value of 28.06% during Q4 2021.
  • For the 3-year period, Ascendis Pharma A's Gross Margin averaged around 83.14%, with its median value being 84.62% (2023).
  • Per our database at Business Quant, Ascendis Pharma A's Gross Margin tumbled by 7,194bps in 2021 and then soared by 4,962bps in 2022.
  • Over the past 5 years, Ascendis Pharma A's Gross Margin (Quarterly) stood at 28.06% in 2021, then soared by 4,962bps to 77.68% in 2022, then skyrocketed by 819bps to 85.87% in 2023, then soared by 607bps to 91.94% in 2024, then soared by 890bps to 89.54% in 2025.
  • Its Gross Margin was 89.54% in Q3 2025, compared to 80.10% in Q2 2025 and 82.65% in Q1 2025.